“Addressing Metabolic Dysfunction‑Associated Steatotic Liver Disease (MASLD) in Endocrinology Settings in Canada: From Prevalence to Patient-Centered Management”. 2025. Canadian Diabetes & Endocrinology Today 3 (s01): 2–8. https://doi.org/10.58931/cdet.2025.3s0144.